|
|
||||||||
1. Intrahypothalamic injection of either dopamine or 5-hydroxytryptamine (5-HT) in a dose volume of 1 microliters caused a fall in core temperature in lightly restrained rats maintained at an ambient temperature of 17 +/- 1 degree C. 2. Haloperidol (6.5 n-mole), a dopamine antagonist, prevented the hypothermic effect of dopamine (65 n-mole), but was ineffective against the response to either intrahypothalamic 5-HT (114 n-mole) or oxotremorine (6.0 n-mole). 3. Methysergide (14 n-mole) and cryproheptadine (17 n-mole) blocked the effect of both 5-HT and dopamine. However, these same doses failed to antagonise the effect of oxotremorine. 4. Rats placed on 0.65 m below a 250 W infra-red lamp responded to the imposed heat load vasodilation of tail skin blood vessels, as indicated by an increased tail skin temperature. 5. Rats tested 2 weeks after bilateral intrahypothalamic injection of 5,6-dihydroxytryptamine (42 n-mole in 2 microliters) showed a significant reduction in their tail skin temperature response and were less able to withstand the imposed heat load. 6. Three serial sections (0.8 mm thick) were prepared from the preoptic area of the rat brain, one anterior, one posterior and one corresponding to the previously defined dopamine-sensitive site. 7. Pretreatment with 5,6-dihydroxytryptamine significantly reduced the 5-HT concentration in the dopamine sensitive site, but had no effect on the concentration of dopamine. This pretreatment blocked dopamine but not 5-HT-induced hypothermia. 8. The 5-hydroxyindoleacetic acid (5HIAA) concentration in the hypothalamus of the normal rat exposed to a heat load was found to be significantly elevated, whereas there was no change in the 5HIAA concentration in the cortex. 9. Slices of rat preoptic hypothalamus and hippocampus were incubated with [3H]5-HT (0.2-2 microM). These slices accumulated 5-HT with properties characteristic of a neuronal uptake process. 10. Perfusion with either dopamine (greater than 50 microM) or apomorphine (greater than 200 microM) enhanced the release of [3H]5-HT from the prelabelled hypothalamic slices, but failed to stimulate release from hippocampal slices. 11. The release of [3H]5-HT from preoptic slices by dopamine and apomorphine was antagonised by the dopamine antagonists haloperidol (2 microM) and (+) isomer of butaclamol (1 microM), the (-) isomer of butaclamol was inactive. 12. These results support the hypothesis of a dopamine-5HT link in the hypothalamic thermoregulatory pathways of the rat.
This article has been cited by other articles:
![]() |
D. E. Rusyniak, M. V. Zaretskaia, D. V. Zaretsky, and J. A. DiMicco 3,4-Methylenedioxymethamphetamine- and 8-Hydroxy-2-di-n-propylamino-tetralin-Induced Hypothermia: Role and Location of 5-Hydroxytryptamine 1A Receptors J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 477 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mundel, S. J. Bunn, P. L. Hooper, and D. A. Jones Human Environmental/Exercise: The effects of face cooling during hyperthermic exercise in man: evidence for an integrated thermal, neuroendocrine and behavioural response Exp Physiol, January 1, 2007; 92(1): 187 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mundel, P. L. Hooper, S. J. Bunn, and D. A. Jones The effects of face cooling on the prolactin response and subjective comfort during moderate passive heating in humans Exp Physiol, November 1, 2006; 91(6): 1007 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Low, A. Purvis, T. Reilly, and N. T. Cable The prolactin responses to active and passive heating in man Exp Physiol, November 1, 2005; 90(6): 909 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Catalina, L. Milewich, W. Frawley, V. Kumar, and M. Bennett Decrease of Core Body Temperature in Mice by Dehydroepiandrosterone Experimental Biology and Medicine, June 1, 2002; 227(6): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Overstreet and V. Djuric Links between multiple chemical sensitivity and asthma in a rat model of cholinergic hypersensitivity: a brief review Toxicology and Industrial Health, June 1, 1999; 15(5): 517 - 521. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |